preloader

1332(E)

(Published in Part II, Section 3, Sub Section (ii) of the
Gazette of India Extraordinary, dated the 5th June, 2008)

Government of India
Ministry of Chemicals and Fertilizers
(National Pharmaceuticals Pricing Authority)

                                                                New Delhi, the 5th June, 2008

ORDER

S.O.1332(E)  – In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:

TABLE

Sl. No. Name of the Formulation Strength Pack Size Ceiling Price (Rs.) Equivalent MRP*(inclusive of all taxes)(Rs.)
(1) (2) (3) (4) (5) (6)

--

Each ml contains

--

1 Dexamethasone+
Ofloxacin+
Phenyl Mercuric
Nitrate Eye/Ear Drop
Dexamethasone Sodium Phosphate – 0.05% w/v
Ofloxacin – 0.3% w/v
Phenyl Mercuric Nitrate-0.001% w/v (as Preservative)
10ml Bottle with Dropper & Carton 9.40 10.35
2 Dexamethasone+
Chloramphenicol +
Phenyl Mercuric
Nitrate Eye/Ear Drop
Dexamethasone Sodium Phosphate – 0.05% w/v
Chloramphenicol – 0.1% w/v
Phenyl Mercuric Nitrate – 0.001% w/v (as Preservative)
10ml Bottle with Dropper & Carton 9.42 10.37
3 Dexamethasone+
Gentamycin+
Methyl Paraben Eye/Ear Drop
Dexamethasone Sodium Phosphate – 0.05% w/v
Gentamicin Sulphate eq. to Gentamicin – 0.3% w/v
Methyl Paraben – 0.1% w/v
10ml Bottle with Dropper & Carton 9.70 10.68

*Subject to actual payment of Government levies/taxes, as applicable.

NOTE :

(a)        The prices fixed are the maximum retail prices in column (6) (inclusive of excise duty and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.

(b)        The companies / manufacturers may added taxes only if they have paid actually to the Government on the price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.

(c)        Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated 27.1.1998 for tablet and capsule packed in strip/blister.

(d)        For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.

(e)        The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by the manufacturing /marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.

(f)        The manufacturer and marketing company for the above said formulation shall be required to take the requisite prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.

(g)        Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the following price order(s) issued prior to this date of notification stand automatically withdrawn :

Sl.No. Price Order No. Date
.

--

--

.and any other price order(s) issued earlier for the composition of the formulation pack for which ceiling price is notified in this notification.

PN/101/2008/F

F.No. 8(11)/2008/D.P./NPPA-Div.II

(RAJIV WADHAWAN)
Deputy Director
National Pharmaceutical Pricing Authority

Last Page Updated: 03-06-2019